logo

For the Inventor, By the Inventor

Saffron Walden, United Kingdom

Roland W Bürli

This inventor holds 18 USPTO granted patents. Top assignees: Chdi Foundation, Inc., Ucb Pharma, S.a., Astrazeneca Ab. Active years: 2013-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland W Bürli. Retrieved from https://idiyas.com/inventor/roland-w-bürli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 94.4

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 67(Granted Patents)


Location History:

  • Saffron Walden Essex, GB (2014 - 2015)
  • Saffron Walden, GB (2013 - 2019)
  • Hertfordshire, GB (2016 - 2022)

Company Filing History:

goldMedal10 out of 56 
 
Chdi Foundation, Inc.
 patents
silverMedal5 out of 180 
 
Ucb Pharma, S.a.
 patents
bronzeMedal3 out of 1,531 
 
Astrazeneca Ab
 patents
4. 2 out of 7 
 
Eolas Therapeutics, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2013-2022

Loading Chart...
18 patents (USPTO):Explore Patents
1. 11434236 - Halo-substituted piperidines as orexin receptor modulators (2022-09-06),
2. 10894789 - Halo-substituted piperidines as orexin receptor modulators (2021-01-19),
3. 10457675 - Histone deacetylase inhibitors and compositions and methods of use thereof (2019-10-29),
4. 10106535 - Histone deacetylase inhibitors and compositions and methods of use thereof (2018-10-23),
5. 10105363 - Histone deacetylase inhibitors and compositions and methods of use thereof (2018-10-23),
6. 10065948 - Histone deacetylase inhibitors and compositions and methods of use thereof (2018-09-04),
7. 10053453 - Compounds and their use as BACE inhibitors (2018-08-21),
8. 9855267 - Histone deacetylase inhibitors and compositions and methods of use thereof (2018-01-02),
9. 9783488 - Histone deacetylase inhibitors and compositions and methods of use thereof (2017-10-10),
10. 9765054 - Histone deacetylase inhibitors and compositions and methods of use thereof (2017-09-19),
11. 9617259 - Histone deacetylase inhibitors and compositions and methods of use thereof (2017-04-11),
12. 9562021 - Histone deacetylase inhibitors and compositions and methods of use thereof (2017-02-07),
13. 9505736 - Histone deacetylase inhibitors and compositions and methods of use thereof (2016-11-29),
14. 8957090 - Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors (2015-02-17),
15. 8785628 - Triazine derivatives as kinase inhibitors (2014-07-22),

Certainly! Here is an article about inventor Roland W Bürli:

Title: Innovator Spotlight: Roland W Bürli

Introduction:

Roland W Bürli is a prolific inventor hailing from Saffron Walden, GB, with a remarkable track record of 18 patents to his name. His contributions have significantly impacted various fields, particularly in pharmaceuticals.

Latest Patents:

One of Bürli's latest patents includes the development of halo-substituted piperidines as orexin receptor modulators. These compounds have shown promise in treating a wide range of conditions, from substance addiction to hypertension, showcasing Bürli's commitment to innovation in healthcare.

Career Highlights:

Throughout his career, Roland W Bürli has been associated with esteemed organizations such as Chdi Foundation, Inc. and UCB Pharma S.A., where he has played a pivotal role in driving research and development initiatives. His dedication to advancing pharmaceutical science is evident in the groundbreaking patents he has secured.

Collaborations:

Bürli is known to have collaborated with industry experts like Alan Findlay Haughan and Celia Dominguez, highlighting his collaborative spirit and ability to work effectively in diverse teams. These partnerships have undoubtedly enriched the innovation landscape in which Bürli operates.

Conclusion:

In conclusion, Roland W Bürli stands out as a visionary inventor whose contributions have reshaped the pharmaceutical landscape. His expertise, coupled with his passion for addressing unmet medical needs, continues to inspire future generations of inventors to push the boundaries of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…